Baird Medical Investment Holdings Ltd

FY: Dec 31 2025

FY: Dec 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Notice of Effectiveness

Post-effective amendment to a registration statement

Registration statement for securities of certain foreign private issuers (amendment)

Post-effective amendment to a registration statement

Registration statement for securities of certain foreign private issuers

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement for securities of certain foreign private issuers

No description available

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Written communication about a business combination transaction (Rule 425)

L1 Capital Global Opportunities Master Fund, Ltd.

ExcelFin SPAC LLC

ExcelFin SPAC LLC

Alta Partners LLC

Lu Rongjian

Qiu Quan

Xu Lijian

Bilciu-Wolfson Gabrielle

Li Jie Clara

Ragan Joseph Douglas III

Hou Wei

WU HAIMEI

No description available

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC